Dena C. Howerton, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 201 Walls Dr Ste 503, Cleburne, TX 76033 Phone: 817-984-9057 |
News Archive
QRxPharma Limited has today announced a Placement which raised A$14 million and which was significantly oversubscribed.
Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.
It's estimated that nearly one-third of all cancer deaths are caused not by the cancer itself but by cachexia-;a debilitating muscle-wasting syndrome that affects an estimated 80 percent of advanced cancer patients. Cachexia is linked to reduced tolerance for cancer therapy, poor quality of life, and accelerated death, but there are no effective treatments and its cause is still largely unknown.
Scientists have discovered that mutations in the histone deacetylase 8 gene can cause the rare genetic disorder known as Cornelia de Lange syndrome, which is characterized by intellectual disability, limb deformity, and other disabilities resulting from problems in early development.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that The Lancet published results from a phase I study investigating the effects of idarucizumab, an investigational agent, in reversing the anticoagulant effect of dabigatran in healthy volunteers. The data demonstrate that complete reversal was achieved following administration of idarucizumab.
› Verified 5 days ago